OxyContin maker reportedly patents drug to treat opioid addiction

Sep 10, 2018

Purdue Pharma has reportedly received a patent for a medication to fight opioid addiction.

According to a report in The Financial Times, the drugmaker of OxyContin has developed a faster-acting form of buprenorphine, which is already use to help ease opioid withdrawal symptoms and curb cravings. The patent is for a wafer-form of the medication that dissolves in seconds.

One of the company’s board members, Richard Sackler, was named as an inventor on the patent.

The news has stirred up criticisms that the company that made billions from getting people hooked on opioids could now profit from treating their addiction. But the company reportedly called the Financial Times story “speculation.”

Purdue, meanwhile, continues to face a litany of lawsuits for its role in the opioid epidemic.

Want to get news like this in your inbox?  Subscribe to our eNewsletter here!

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments